Arjo Financial Statements From 2010 to 2025

ARJO-B Stock  SEK 38.68  0.72  1.90%   
Arjo AB financial statements provide useful quarterly and yearly information to potential Arjo AB investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Arjo AB financial statements helps investors assess Arjo AB's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Arjo AB's valuation are summarized below:
Arjo AB does not presently have any fundamental signals for analysis.
Check Arjo AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arjo AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Arjo financial statements analysis is a perfect complement when working with Arjo AB Valuation or Volatility modules.
  
This module can also supplement various Arjo AB Technical models . Check out the analysis of Arjo AB Correlation against competitors.

Arjo AB Company Current Valuation Analysis

Arjo AB's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Arjo AB Current Valuation

    
  12.09 B  
Most of Arjo AB's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arjo AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Arjo AB has a Current Valuation of 12.09 B. This is 15.84% lower than that of the Healthcare sector and 8.76% lower than that of the Medical Distribution industry. The current valuation for all Sweden stocks is 27.29% higher than that of the company.

Arjo AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Arjo AB's current stock value. Our valuation model uses many indicators to compare Arjo AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arjo AB competition to find correlations between indicators driving Arjo AB's intrinsic value. More Info.
Arjo AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.54  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Arjo AB is roughly  1.84 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Arjo AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Arjo AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Arjo AB Financial Statements

Arjo AB stakeholders use historical fundamental indicators, such as Arjo AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Arjo AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Arjo AB's assets and liabilities are reflected in the revenues and expenses on Arjo AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Arjo AB. Please read more on our technical analysis and fundamental analysis pages.
Arjo AB develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. The company was founded in 1957 and is headquartered in Malmo, Sweden. Arjo AB is traded on Stockholm Stock Exchange in Sweden.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Arjo Stock

Arjo AB financial ratios help investors to determine whether Arjo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arjo with respect to the benefits of owning Arjo AB security.